Generic drugmaker Teva Pharmaceutical Industries, Jerusalem, on Tuesday completed a $4.95 billion buyout of German drugmaker Ratiopharm.
Teva acquires German drugmaker for $4.95 billion
Teva is the world's largest maker of generic drugs, and said it is now the largest generics maker in Europe. Teva said it expects to be able to save at least $400 million per year from the deal. Those savings will take effect within three years, the company said.
The deal was announced in March. Teva Pharmaceutical is based in Jerusalem but makes most of its sales in North America.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.